Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT05924997 · UNKNOWN
Trial details
- NCT number
- NCT05924997
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-06-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.